OTC Artificial Tears Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033

Buy Now
Excel: 8 Hours
PDF: 24 Hours
Feb 2025
Pages: 220

FAQs

The global OTC Artificial Tears market size was valued at US$ 4.70 billion in 2024 and is expected to reach US$ 7.22 billion in 2033.

The global OTC Artificial Tears market is expected to expand at a compound annual growth rate (CAGR) of 4.88% from 2025 to 2033.

Some key players operating in the OTC Artificial Tears market includes AbbVie Inc., Akorn Inc., Alcon, Bausch Health Companies Inc., Johnson & Johnson, Nicox S.A., Novartis AG, Santen Pharmaceutical Co. Ltd., and Sun Pharmaceutical Industries Ltd. 

Growing digital eye strain, an increase in dry eye instances, aging populations, environmental issues including pollution and dry weather, expanding consumer awareness, and the need for contact lens-friendly and preservative-free solutions are some of the drivers propelling the over-the-counter (OTC) artificial tears market.

North America is expected to hold the largest market share in the industry.

Product Type, Application, Distribution Channel, and Countries segment are covered in this report.